Xybercyl Device
XyberCyl Open Study
In pre-clinical open (onlay) porcine studies conducted by XyberCyl, XyberCyl and a leading surgical mesh product (Product “P”) were implanted. Non-implanted control areas were designated in each test subject. The results were quite compelling: XyberCyl was superior to Product “P” in every parameter.
Laparoscopic Study
In pre-clinical laparoscopic porcine studies conducted for XyberCyl by Dr. Salvador Morales-Conde in Spain, XyberCyl and a leading surgical mesh product (Product “V”) were implanted. The results were quite compelling: XyberCyl was superior or equivalent to Product “V” when measuring key parameters.
The Invisible Surgical Mesh
The issues with surgical mesh (e.g. shrinkage, chronic pain, chronic infection, failure, etc.) are well-known, and have been well-documented and well-litigated.
New product releases by surgical mesh companies have many times been innovative – addressing one specific issue, yet ignoring other serious issues. For example, Product “V” acquired an innovative coating technology that significantly reduces the risk of adhesions – yet this mesh is still recognized as a foreign body, often shrinks and even folds. Product “U” is innovative in that it is large-pore – allowing for better integration into the surrounding tissue – yet its knitted construct generates a foreign-body reaction with all of its related issues.
XyberCyl, on the other hand, is both innovative and inclusive – an innovative construct that is invisible to the human body and inclusively addresses all issues typically experienced with other surgical meshes.